ARCHIVES

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

This article is from The Cancer Letter archive.

Vol. 18 No. 09 | February 28, 1992

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012